Dr Reddy's Labs arm to sell certain assets, liabilities of Netherlands site Ruchika Sharma19 Dec 2022 11:32 AM IST"The agreed consideration for the assets and liabilities of the said site is EUR 1. Further DRRDBV has agreed to pay to the purchaser a compensation...
Dr Reddy's Labs arm Aurigene reports results of AUR101 in Phase II study in patients with moderate to severe psoriasis Ruchika Sharma16 Dec 2022 12:25 PM ISTAUR-101 is a potent, oral RORÏ’t inverse agonist, with high selectivity across other ROR isoforms and nuclear hormone receptors and expected to confer...
Submit in vitro data and comparative data: CDSCO Tells Dr Reddy's on Icosapent Ethyl Capsule Dr. Divya Colin13 Dec 2022 6:00 PM ISTNew Delhi: Noting that the effect of Icosapentether on the risk of pancreatitis in patients with severe hypertriglyceridemia has yet to be determined,...
Sun Pharma, Dr Reddy's Labs recall products in US over manufacturing issues Ruchika Sharma5 Dec 2022 1:30 PM ISTThe health regulator further said the US-based arm of Sun Pharma is recalling 14,064 cartons of a medication to treat erosive esophagitis or heartburn...
Shared Monopoly in sale of generic Revlimid: Dr Reddy's Labs, Bristol Myers Squibb and others face anti-trust litigation in US Ruchika Sharma23 Nov 2022 11:52 AM ISTThe company said the complaint "alleges that the challenged agreements improperly delayed generic entry entirely until 2022 and then improperly...
Dr Reddy's Labs earmarks Rs 1,500 crore capex with focus on biosimilars, injectables Ruchika Sharma7 Nov 2022 2:30 PM ISTNew Delhi: Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities...
Dr Reddys Labs bags CDSCO panel conditional nod to manufacture, market Nimesulide Granules Dr. Nandita Mohan22 Oct 2022 1:18 PM IST Stressing that the drug product should only be made available with a prescription from a Registered Medical Practitioner, the Subject Expert...
US Supreme Court turns down Novartis bid to block launch of multiple sclerosis drug Gilenya generics Ruchika Sharma15 Oct 2022 1:30 PM ISTNovartis settled with some of the drugmakers it had sued, allowing for some Gilenya generics before a key patent's 2027 expiration.
Dr Reddy's Labs, Cipla facilities join World Economic Forum Global Lighthouse Network Ruchika Sharma12 Oct 2022 12:08 PM ISTOn Cipla, the WEF said the company deployed digital, automation and analytics solutions to 22 Indian sites to preserve access to high-quality...
LIC increases its stake in Dr Reddy's Laboratories from 5.65 percent to 7.7 percent Ruchika Sharma4 Oct 2022 11:01 AM ISTLIC's holding in the company stands at 7.7 percent, it added.
Dr Reddy's Labs, IQVIA ink pact for CRM solution for India field force Ruchika Sharma29 Sept 2022 11:15 AM ISTOCE is IQVIA's CRM Application Suite that enables life sciences clients to digitally transform their sales and marketing operations.
Dr Reddy's Labs, DNDi ink pact to develop affordable drugs for neglected tropical diseases Ruchika Sharma1 Sept 2022 3:41 PM ISTNew Delhi: Dr. Reddy's Laboratories Ltd. and Aurigene Pharmaceutical Services Limited, a contract research, development, and manufacturing services...
